2022 American Transplant Congress Archives - Page 3 of 190

3:30pm-3:40pm: Tabelecleucel (Tab-cel) for Solid Organ (SOT) or Allogeneic Hematopoietic Cell Transplant (HCT) Recipients with Epstein-Barr Virus-Driven Post Transplant Lymphoproliferative Disease (EBV⁺ PTLD) After Failure Of Rituximab (R) ± Chemotherapy (CT) (ALLELE)

S. Prockop¹, A. Beitinjaneh², S. Choquet³, S. Dahiya⁴, R. Dinavahi⁵, R. Farah⁶, L. Gamelin⁵, A. Joshi⁵, A. Mehta⁵, P. Nayak⁵, R. Reshef⁷, G. Satyanarayana⁸, P. Stiff⁹, W. Ye⁵, K. M. Mahadeo¹⁰

PTLD and Malignancies • Hynes Room 309

3:40pm-3:50pm: Clinical Efficacy of Adjuvant Immunotherapy for Liver Transplant Recipients with Exceeding Japan Criteria of Hepatocellular Carcinoma Using Donor Liver Derived Natural Killer Cells

M. Ohira¹, Y. Imaoka², K. Sato³, K. Imaoka¹, N. Tanimine¹, H. Tahara¹, K. Ide¹, T. Kobayashi¹, Y. Tanaka¹, A. G. Tzakis⁴, S. Nishida⁵, H. Ohdan¹

Hepatocellular Carcinoma and Other Malignancies • Hynes Room 312

3:40pm-3:50pm: Clinical Outcomes of Solid Organ Transplant (SOT) Patients with Epstein-Barr Virus-Driven (EBV⁺) Post-Transplant Lymphoproliferative Disease (PTLD) Who Fail Rituximab Plus Chemotherapy: A Multinational, Retrospective Chart Review Study

V. Dharnidharka¹, D. Thirumalai², U. Jaeger³, W. Zhao², D. Dierickx⁴, P. Xun², P. Minga⁵, A. Sawas⁶, N. Sadetsky⁷, P. Chauvet⁸, E. Sundaram⁹, A. Barlev⁷, H. Zimmermann¹⁰, R. U. Trappe¹⁰

PTLD and Malignancies • Hynes Room 309

3:40pm-3:50pm: Exploring the Differential Access Hypothesis: Do Black Kidney Transplant Candidates Have Less Social Network Access to Potential Living Donors Than White Candidates?

J. Daw¹, M. Roberts¹, T. Purnell²

Kidney Psychosocial • Hynes Ballroom A

3:40pm-3:50pm: HLA DSA May Not Be Detected in Many Solid Organ Recipients

J. C. Quon¹, R. M. Lestz², J. Menteer², N. Fotiadis², L. A. Baxter-Lowe²

Histocompatibility and Endothelial/Lymphatic Cell Biology • Hynes Room 310

3:40pm-3:50pm: Humoral Response After a Third Dose of Sars-CoV-2 mRNA Vaccine in Transplant Recipients

A. E. Woolley, N. Sharma, G. Zhou, A. Kim, E. Ryan, M. Joyce, H. Goldberg, M. Givertz, M. Mehra, E. Woodcome, V. Durney, S. Marshall, K. Townsend, A. Coppolino, S. Tullius, S. Malek, H. Mallidi, L. Baden, A. Chandraker

Infectious Considerations for Lung Transplantation • Hynes Room 210

3:40pm-3:50pm: Long-Term (>1 Year) Rejection Free Graft Survival of Kidney Xenografts with Triple Xenoantigen Knockout and Multiple Human Transgenes in Cynomolgus Monkeys

T. Hirose¹, G. Lassiter¹, D. Ma¹, A. D'Attilio¹, I. Rosales¹, D. Cloonan¹, R. Matheson¹, R. Colvin¹, W. Qin², Y. Kan², J. Layer², R. Anand², V. Paragas², L. Queroz², X. Tan², I. Kohnle², K. Stiede², K. Hall², M. Youd², M. Curtis², J. Markmann¹, T. Kawai¹

Xenotransplantation • Hynes Room 302

3:40pm-3:50pm: Phase I/ii Car-Treg Cell Therapy Clinical Trial To Induce Long-term Tolerance In Liver Transplant Patients

A. Sanchez-Fueyo¹, A. Taylor¹, D. Collin², C. Nathalie², S. Chris², M. Martinez-Llordella², N. Belmonte², I. McGill², D. Hartl²

Late Breaking: Clinical • Hynes Room 313

3:40pm-3:50pm: Post-Kidney Transplant Valacyclovir versus Valganciclovir for CMV Prophylaxis: A Randomized Controlled Trial

P. S. Verghese¹, A. Matas², S. Chinnakotla², M. Evans³, H. Balfour Jr⁴

Cytomegalovirus and other Herpes Viruses • Hynes Ballroom B

3:40pm-3:50pm: Social Determinants of Health Impact Successful Listing for Liver and Kidney Transplant

J. B. Henson, D. Mohottige, J. M. Wilder, A. J. Muir, L. M. McElroy

Disparities to Outcome and Access to Healthcare • Hynes Room 311